We are live on ! Find out more
IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

53 hedge funds and large institutions have $77.1M invested in Intermolecular, Inc. in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% more ownership

Funds ownership: 33.35%33.5% (+0.14%)

9% less capital invested

Capital invested by funds: $84.7M → $77.1M (-$7.6M)

15% less funds holding

Funds holding: 6253 (-9)

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
53
Holders Change
-9
Holders Change %
-14.52%
% of All Funds
1.53%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
17
Reduced
23
Closed
15
Calls
Puts
Net Calls
Net Calls Change

IMI Hedge Fund Activity: Q4 2013 in Review

53 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q4 2013, worth a combined $77.1M — down 9% from $84.7M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IMI and 6 opened new positions — a net loss of 9 holders — while 23 trimmed existing stakes and 17 added.

The largest buyer was RGM Capital, opening a new position worth an estimated $10.5M. The largest seller was Kendall Square Capital, cutting an estimated $6.83M.

  • 53 institutional investors held Intermolecular, Inc. (IMI) as of Q4 2013, down from 62 in Q3 2013.
  • Funds reported $77.1M of Intermolecular, Inc. stock for Q4 2013, down 9% quarter-over-quarter.
  • 6 funds opened new Intermolecular, Inc. positions in Q4 2013 and 15 closed out, a net change of -9 holders.
  • The largest Intermolecular, Inc. buyer in Q4 2013 was RGM Capital, an estimated $10.5M added.
  • The largest Intermolecular, Inc. seller in Q4 2013 was Kendall Square Capital, an estimated $6.83M sold.

Based on aggregated 13F filings for Q4 2013.